Classification of Lung Adenocarcinoma Based on Immune Checkpoint and Screening of Related Genes.
Ting ZhouPing YangSanyuan TangZhongshan ZhuXiaobing LiZhou YangRuoxia WuXuefei TianLiang LiPublished in: Journal of oncology (2021)
We established a nine-gene signature based on immune checkpoints, which may contribute to the diagnosis, prognosis, and clinical treatment of LUAD.